According to a recent LinkedIn post from Resilience Care, the company plans to participate again in the SantExpo 2026 healthcare exhibition in Paris. The post frames the French health system as under pressure, with care pathways seen as fragmented and health data not fully leveraged to guide care and clinical routines.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights Resilience Care’s focus on telemonitoring as a tool to improve continuity of care, optimize medical time and hospital organization, and enhance interoperability and use of health data for care and research. The company indicates that its telemonitoring solutions in oncology, psychiatry, and gastroenterology are already deployed in more than 200 healthcare facilities.
For investors, recurring participation in a major industry event such as SantExpo suggests continued business development efforts and visibility among French healthcare providers. The reference to deployment in over 200 establishments may indicate growing commercial traction and a potentially expanding installed base for its digital health solutions.
If the company can deepen adoption of its telemonitoring tools in high-need specialties, it could benefit from rising demand for efficiency and remote care in European healthcare systems. Emphasis on interoperability and data use may also position Resilience Care within broader trends around real-world data, potentially supporting future product enhancement or data-driven partnerships.